CIK: 1437435 - Address: C/o Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/28/22 19:30
11/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-61030.480-20-12,107D
11/3/22 17:37
11/1/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.m-60530.270-20-12,127D
10/3/22 16:05
9/29/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.dm-7,611702.240-11-832D
9/30/22 16:50
9/28/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-61630.820-20-12,147D
8/25/22 18:11
8/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-63231.610-20-12,167D
7/27/22 18:49
7/25/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-71235.610-20-12,187D
6/28/22 15:07
3/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.a-67733.830-20-12,261D
3/25/22 17:57
3/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-67733.830-20-12,261D
3/23/22 16:01
3/21/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-5,133690.000-7-772D
3/18/22 16:05
3/16/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.dm-8,268678.210-12-842D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact